Francesca Casaluce

1.1k total citations
38 papers, 841 citations indexed

About

Francesca Casaluce is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Francesca Casaluce has authored 38 papers receiving a total of 841 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Pulmonary and Respiratory Medicine, 30 papers in Oncology and 12 papers in Molecular Biology. Recurrent topics in Francesca Casaluce's work include Lung Cancer Treatments and Mutations (30 papers), Lung Cancer Research Studies (18 papers) and Cancer Immunotherapy and Biomarkers (10 papers). Francesca Casaluce is often cited by papers focused on Lung Cancer Treatments and Mutations (30 papers), Lung Cancer Research Studies (18 papers) and Cancer Immunotherapy and Biomarkers (10 papers). Francesca Casaluce collaborates with scholars based in Italy, Spain and United States. Francesca Casaluce's co-authors include Cesare Gridelli, Assunta Sgambato, Paolo Maione, Fortunato Ciardiello, Antônio Rossi, Paola Claudia Sacco, Giovanni Palazzolo, Alex A. Adjei, Solange Peters and Giuseppe Santabarbara and has published in prestigious journals such as Annals of Oncology, Nature Reviews Clinical Oncology and Current Medicinal Chemistry.

In The Last Decade

Francesca Casaluce

37 papers receiving 826 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Francesca Casaluce Italy 15 512 462 326 140 82 38 841
Assunta Sgambato Italy 15 441 0.9× 416 0.9× 293 0.9× 125 0.9× 66 0.8× 31 742
Paola Claudia Sacco Italy 18 505 1.0× 438 0.9× 340 1.0× 135 1.0× 89 1.1× 42 889
Jih‐Hsiang Lee Taiwan 19 669 1.3× 561 1.2× 347 1.1× 196 1.4× 73 0.9× 37 1.0k
Sara Baglivo Italy 17 661 1.3× 541 1.2× 306 0.9× 187 1.3× 109 1.3× 39 993
Ken Uchibori Japan 15 567 1.1× 614 1.3× 360 1.1× 156 1.1× 67 0.8× 59 885
Junko Hamamoto Japan 16 446 0.9× 535 1.2× 408 1.3× 153 1.1× 45 0.5× 27 808
Ichiro Kawada Japan 18 576 1.1× 673 1.5× 516 1.6× 180 1.3× 67 0.8× 56 1.1k
Joseph Chen United States 13 452 0.9× 527 1.1× 240 0.7× 110 0.8× 37 0.5× 27 801
Caicun Zhou China 12 435 0.8× 393 0.9× 197 0.6× 106 0.8× 82 1.0× 36 710
Erina Hatashita Japan 15 579 1.1× 492 1.1× 588 1.8× 130 0.9× 58 0.7× 17 1.0k

Countries citing papers authored by Francesca Casaluce

Since Specialization
Citations

This map shows the geographic impact of Francesca Casaluce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca Casaluce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca Casaluce more than expected).

Fields of papers citing papers by Francesca Casaluce

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesca Casaluce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca Casaluce. The network helps show where Francesca Casaluce may publish in the future.

Co-authorship network of co-authors of Francesca Casaluce

This figure shows the co-authorship network connecting the top 25 collaborators of Francesca Casaluce. A scholar is included among the top collaborators of Francesca Casaluce based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesca Casaluce. Francesca Casaluce is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Casaluce, Francesca & Cesare Gridelli. (2021). Narrative review of lung cancer treatment at the time of COVID-19 pandemia: pitfall and issues. Translational Lung Cancer Research. 10(1). 475–482. 4 indexed citations
2.
Casaluce, Francesca, et al.. (2018). Lung cancer, elderly and immune checkpoint inhibitors. Journal of Thoracic Disease. 10(S13). S1474–S1481. 22 indexed citations
3.
Gridelli, Cesare, Paul Baas, Fabrice Barlési, et al.. (2017). Second-Line Treatment Options in Non–Small-Cell Lung Cancer: Report From an International Experts Panel Meeting of the Italian Association of Thoracic Oncology. Clinical Lung Cancer. 19(4). 301–314. 8 indexed citations
4.
Gridelli, Cesare, Paolo A. Ascierto, Massimo Barberis, et al.. (2016). Immunotherapy of non-small cell lung cancer: report from an international experts panel meeting of the Italian association of thoracic oncology. Expert Opinion on Biological Therapy. 16(12). 1479–1489. 12 indexed citations
5.
Casaluce, Francesca, Assunta Sgambato, Giovanni Palazzolo, et al.. (2016). Resistance to Crizotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) with ALK Rearrangement: Mechanisms, Treatment Strategies and New Targeted Therapies. Current Clinical Pharmacology. 11(2). 77–87. 26 indexed citations
6.
Rossi, Antônio, Paola Claudia Sacco, Assunta Sgambato, et al.. (2016). Optimal drugs for second-line treatment of patients with small-cell lung cancer. Expert Opinion on Pharmacotherapy. 17(7). 969–976. 13 indexed citations
7.
8.
Sacco, Paola Claudia, Paolo Maione, Antônio Rossi, et al.. (2015). Necitumumab for the treatment of stage IV metastatic squamous non-small-cell lung cancer. Expert Review of Respiratory Medicine. 9(3). 245–254. 3 indexed citations
9.
Maione, Paolo, Antônio Rossi, Assunta Sgambato, et al.. (2015). New Antiangiogenetic Therapy Beyond Bevacizumab in the Treatment of Advanced Non Small Cell Lung Cancer. Current Pharmaceutical Design. 21(32). 4763–4772. 4 indexed citations
10.
Rossi, Emanuela, Assunta Sgambato, Francesca Casaluce, et al.. (2015). Endocrinopathies induced by immune-checkpoint inhibitors in advanced non-small cell lung cancer. Expert Review of Clinical Pharmacology. 9(3). 419–428. 23 indexed citations
11.
Sacco, Paola Claudia, Francesca Casaluce, Assunta Sgambato, et al.. (2015). Current challenges of lung cancer care in an aging population. Expert Review of Anticancer Therapy. 15(12). 1419–1429. 9 indexed citations
12.
Maione, Paolo, Antônio Rossi, Clorinda Schettino, et al.. (2014). Irreversible EGFR Inhibitors in the Treatment of Advanced NSCLC. Current Pharmaceutical Design. 20(24). 3894–3900. 10 indexed citations
13.
Casaluce, Francesca, Assunta Sgambato, Paola Claudia Sacco, et al.. (2014). Emerging drugs targeting PD-1 and PD-L1: reality or hope?. Expert Opinion on Emerging Drugs. 19(4). 557–569. 10 indexed citations
14.
Rossi, Antônio, Paolo Maione, Paola Claudia Sacco, et al.. (2014). ALK inhibitors and advanced non-small cell lung cancer (Review). International Journal of Oncology. 45(2). 499–508. 26 indexed citations
15.
Sgambato, Assunta, Francesca Casaluce, Paolo Maione, et al.. (2013). Medical treatment of small cell lung cancer: state of the art and new development. Expert Opinion on Pharmacotherapy. 14(15). 2019–2031. 20 indexed citations
16.
Casaluce, Francesca, Assunta Sgambato, Paolo Maione, Fortunato Ciardiello, & Cesare Gridelli. (2013). Emerging mitotic inhibitors for non-small cell carcinoma. Expert Opinion on Emerging Drugs. 18(1). 97–107. 10 indexed citations
17.
Gridelli, Cesare, Solange Peters, Assunta Sgambato, et al.. (2013). ALK inhibitors in the treatment of advanced NSCLC. Cancer Treatment Reviews. 40(2). 300–306. 142 indexed citations
18.
Maione, Paolo, et al.. (2013). Selumetinib in Advanced Non Small Cell Lung Cancer (NSCLC) Harbouring KRAS Mutation: Endless Clinical Challenge to KRAS-mutant NSCLC.. Reviews on Recent Clinical Trials. 8(2). 93–100. 12 indexed citations
19.
Schettino, Clorinda, Maria Anna Bareschino, Paolo Maione, et al.. (2013). New Molecular Targets in the Treatment of NSCLC. Current Pharmaceutical Design. 19(30). 5333–5343. 24 indexed citations
20.
Sgambato, Alessandro, Francesca Casaluce, Antônio Rossi, et al.. (2012). The Role of EGFR Tyrosine Kinase Inhibitors in the First-Line Treatment of Advanced Non Small Cell Lung Cancer Patients Harboring EGFR Mutation. Current Medicinal Chemistry. 19(20). 3337–3352. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Assunta Sgambato Breakdown of academic impact, for papers by Paola Claudia Sacco Breakdown of academic impact, for papers by Jih‐Hsiang Lee Breakdown of academic impact, for papers by Sara Baglivo Breakdown of academic impact, for papers by Ken Uchibori Breakdown of academic impact, for papers by Junko Hamamoto Breakdown of academic impact, for papers by Ichiro Kawada Breakdown of academic impact, for papers by Joseph Chen Breakdown of academic impact, for papers by Caicun Zhou Breakdown of academic impact, for papers by Erina Hatashita
Rankless by CCL
2026